uniQure N.V. (NASDAQ:QURE) shares are popping on Friday after the company said the FDA will review the data package for AMT‑130, its gene therapy for Huntington’s disease, with a Type A meeting now scheduled.
uniQure shares are powering higher. Why is QURE stock up today?
What Happened: According to the FDA, Type A meetings are typically reserved for discussions needed if program setbacks or regulatory disputes arise.
“We look forward to a constructive discussion with the FDA as we work toward a timely resolution regarding an accelerated approval pathway for AMT-130,” said Matt Kapusta, CEO at uniQure.
Kapusta said patients, families and doctors continue to highlight the urgent need for treatments that can slow or change the course of Huntington’s disease.
UniQure plans to share a regulatory update once it receives the official meeting minutes.
Is QURE A Good Stock To Buy?
An investor can make a few decisions when deciding whether a stock is a good buy. In addition to valuation metrics and price action which you can find on Benzinga’s quote pages — like uniQure‘s page for example — there are factors like whether or not a company pays a dividend or buys a large portion of its stock each quarter.
These are known as capital allocation programs. uniQure (NASDAQ:QURE) does not pay a dividend, but obviously has a few ways it can return value to shareholders. Feel free to search Benzinga’s dividend calendar for the next company that is due to pay a dividend and determine what kind of yield you can earn for holding a share of the company.
For example, if you’re looking to earn an annualized return of 18.01%, you’ll need to buy a share of Ellington Residential by the Jan. 30, 2026. Once done, you can expect to receive a nominal payout of 8 cents on Feb. 27, 2026.
Buyback programs are obviously different and highly variable. A company can approve a buyback program and purchase shares as it sees fit over the course of time in which the buyback was authorized. Looking through the latest news on uniQure will often yield whether or not the company has approved a buyback program recently. Buyback programs usually serve as a support for share prices, serving as a backstop for demand.
QURE Price Action: uniQure shares were up 10.84% at $25.66 at the time of publication on Friday, according to Benzinga Pro.
Image: Gorodenkoff/Shutterstock
Recent Comments